Literature DB >> 11943165

Recombinant glucocorticoid induced tumor necrosis factor receptor (rGITR) induces NOS in murine macrophage.

Hyun Hee Shin1, Moo Hyung Lee, Suk Gi Kim, Yun Hwa Lee, Byoung S Kwon, Hye Seon Choi.   

Abstract

Glucocorticoid induced tumor necrosis factor receptor (GITR) is a new member of the tumor necrosis factor-nerve growth factor receptor superfamily of which the function has not been well studied. The extracellular domain of GITR was produced in Escherichia coli and purified as a single band of predicted M(r) of 18.0 kDa. GITR and GITR ligand were expressed constitutively on the surface of Raw 264.7 macrophage cell line and murine peritoneal macrophages. An extracellular domain of GITR can activate murine macrophages to express inducible nitric oxide synthase and to generate nitric oxide in a dose- and time-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11943165     DOI: 10.1016/s0014-5793(02)02379-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  15 in total

1.  The glucocorticoid-induced TNF receptor family-related protein (GITR) is critical to the development of acute pancreatitis in mice.

Authors:  M Galuppo; G Nocentini; E Mazzon; S Ronchetti; E Esposito; L Riccardi; P Sportoletti; R Di Paola; S Bruscoli; C Riccardi; S Cuzzocrea
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

Review 2.  Sequence, structure, function, immunity: structural genomics of costimulation.

Authors:  Kausik Chattopadhyay; Eszter Lazar-Molnar; Qingrong Yan; Rotem Rubinstein; Chenyang Zhan; Vladimir Vigdorovich; Udupi A Ramagopal; Jeffrey Bonanno; Stanley G Nathenson; Steven C Almo
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

3.  Blockade of GITR-GITRL interaction maintains Treg function to prolong allograft survival.

Authors:  James I Kim; Samsher B Sonawane; Major K Lee; Seoung-Hoon Lee; Patrick E Duff; Daniel J Moore; Matthew R O'Connor; Moh-Moh Lian; Shaoping Deng; Yongwon Choi; Heidi Yeh; Andrew J Caton; James F Markmann
Journal:  Eur J Immunol       Date:  2010-05       Impact factor: 5.532

4.  An isoleucine-zipper motif enhances costimulation of human soluble trimeric GITR ligand.

Authors:  Dawei Cui; Shengjun Wang; Yu Chen; Jia Tong; Jie Ma; Li Tang; Xianzhi Yang; Ye Shi; Jie Tian; Liwei Lu; Huaxi Xu
Journal:  Cell Mol Immunol       Date:  2010-03-15       Impact factor: 11.530

5.  GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice.

Authors:  L Santucci; M Agostini; S Bruscoli; A Mencarelli; S Ronchetti; E Ayroldi; A Morelli; M Baldoni; C Riccardi
Journal:  Gut       Date:  2006-06-08       Impact factor: 23.059

Review 6.  TNF superfamily: costimulation and clinical applications.

Authors:  Dass S Vinay; Byoung S Kwon
Journal:  Cell Biol Int       Date:  2009-02-20       Impact factor: 3.612

7.  Glucocorticoid-induced tumor necrosis factor receptor negatively regulates activation of human primary natural killer (NK) cells by blocking proliferative signals and increasing NK cell apoptosis.

Authors:  Baoying Liu; Zhuqing Li; Sankaranarayana P Mahesh; Seth Pantanelli; Frank S Hwang; Willie O Siu; Robert B Nussenblatt
Journal:  J Biol Chem       Date:  2008-01-29       Impact factor: 5.157

8.  Localized expression of GITR-L in the tumor microenvironment promotes CD8+ T cell dependent anti-tumor immunity.

Authors:  John S Cho; Jeffrey V Hsu; Sherie L Morrison
Journal:  Cancer Immunol Immunother       Date:  2008-11-19       Impact factor: 6.968

9.  Assembly and structural properties of glucocorticoid-induced TNF receptor ligand: Implications for function.

Authors:  Kausik Chattopadhyay; Udupi A Ramagopal; Arunika Mukhopadhaya; Vladimir N Malashkevich; Teresa P Dilorenzo; Michael Brenowitz; Stanley G Nathenson; Steven C Almo
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-26       Impact factor: 11.205

10.  Key role of the GITR/GITRLigand pathway in the development of murine autoimmune diabetes: a potential therapeutic target.

Authors:  Sylvaine You; Lynn Poulton; Steve Cobbold; Chih-Pin Liu; Michael Rosenzweig; Douglas Ringler; Wen-Hui Lee; Berta Segovia; Jean-François Bach; Herman Waldmann; Lucienne Chatenoud
Journal:  PLoS One       Date:  2009-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.